Stock data
Upstream Bio, Inc. (UPB)
Upstream Bio, Inc. (UPB) reported revenue of US$2.85M and net income of -US$143.44M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$2.85M | — | -US$160.36M | -US$143.44M | — |
| 2024 | US$2.37M | — | -US$77.76M | -US$62.81M | — |
| 2023 | US$2.38M | — | -US$40.11M | -US$20.54M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.77M | -US$39.70M | — |
| 2026-03-31 | US$1.03M | -US$40.59M | — |
| 2025-12-31 | US$0.67M | -US$42.46M | — |
| 2025-09-30 | US$0.68M | -US$33.75M | — |
| 2025-06-30 | US$0.94M | -US$39.97M | — |
| 2025-03-31 | US$0.57M | -US$27.27M | — |
| 2024-12-31 | US$0.61M | -US$21.24M | — |
| 2024-09-30 | US$0.61M | -US$15.99M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.